Frontlight ResearchEarly access
Taking peoplePhase 4
MRI contrast injected near the spine to study brain fluid flow in adults
Tests MRI contrast given into spinal fluid to study fluid movement in adults.
Key facts
- Who runs it
- Oslo University Hospital HF
- Where
- Norway1 site in 1 countryChoose a country to see its sites
- Registry title
- Intrathecal MRI Contrast for Assessment of CSF Transport
- Status
- Recruiting
- Phase
- Phase 4
- People taking part
- 1,000 people, planned
- Started
- 29 Jan 2025
- Expected to end
- 31 Dec 2030
- Type of study
- Interventional
- Record updated
- 2 November 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with brain symptoms or brain or spinal cord disease. It uses MRI contrast given into the spinal fluid to study how this fluid flows and clears.
- Age
- 18 to 80 years
- Sex
- All sexes
- Disease stage
- Brain symptoms such as cognitive impairment (problems with thinking or memory) and fatigue. Or imaging signs of nervous system disease, such as CSF disorders, hydrocephalus (fluid build-up in the brain) or tumours in the central nervous system.
- Earlier treatment
- People getting treatment aimed at the brain and spinal cord can join. This includes chemotherapy given into the spinal fluid to stop tumour spread.
Main reasons for not taking part
- Allergy to contrast agents
- Kidney failure
- Younger than 18 or older than 80 years
- Pregnant women
- Women who are breastfeeding
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Individuals with cerebral symptoms (including cognitive impairment and fatigue)
- Individuals with imaging evidence of neurological disease (CSF disorders, hydrocephalus, neoplasia in central nervous system)
- Individuals who receive medical treatment intended to treat the CNS (patients receiving intrathecal chemotherapeutic drugs to prevent tumor spread)
Who cannot take part
- Contrast allergy
- Renal failure
- < 18 years of age or >80 years of age
- Pregnant women
- Women who are breastfeeding
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Individualized assessment of CSF flow in CSF spaces and CNS Individualized assessment of CSF clearance
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record
Print a page for my doctorData and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
- Official title
- Intrathecal MRI Contrast for Assessment of CSF Transport
- Plain-language title
- MRI contrast injected near the spine to study brain fluid flow in adultsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 2 November 2026